dinitrofluorobenzene has been researched along with Dermatitis, Atopic in 95 studies
*Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (3.16) | 18.7374 |
| 1990's | 2 (2.11) | 18.2507 |
| 2000's | 12 (12.63) | 29.6817 |
| 2010's | 48 (50.53) | 24.3611 |
| 2020's | 30 (31.58) | 2.80 |
| Authors | Studies |
|---|---|
| Mandlik, DS; Mandlik, SK; Patel, SS | 1 |
| Hamasaki, Y; Horikami, D; Inagaki, S; Inuzuka, Y; Kobayashi, K; Murata, T; Nagata, N; Nakamura, T; Narita, M; Ohya, Y; Shimosawa, T; Yamamoto-Hanada, K | 1 |
| Cao, X; Chen, L; Ding, H; Gao, J; Tang, L; Wang, H | 1 |
| Sun, YJ; Wang, BY; Xiao, WL; Yang, C; Zhao, BT; Zheng, BW | 1 |
| Chen, L; Ding, H; Gao, JF; Luo, F; Meng, ZD; Tang, L; Zhang, YY | 1 |
| Abdelazeem, KNM; Cao, Z; Chen, H; El-Aziz, TMA; Jiang, S; Jiao, K; Ren, Y; Tan, L; Tang, Q; Wang, Y; Xue, C; Yu, Y; Zhao, F; Zhu, MX | 1 |
| Feng, L; Hou, C; Kong, L; Liu, C; Ni, G; Sun, T; Wang, D; Yu, S; Yu, Z; Zhang, X; Zhang, Y | 1 |
| He, C; Jiang, X; Li, J; Li, M; Liu, Q; Wang, N | 1 |
| Jiang, P; Liu, L; Song, Z; Wu, Y; Zhang, L | 1 |
| Deng, J; Liu, Y; Shao, H; Tang, Z; Wu, G; Yang, N; Yang, Y | 1 |
| Cao, X; Gao, J; Li, X; Tang, L; Zhou, B | 1 |
| Chen, L; Ding, H; Gao, JF; Luo, F; Tang, L; Zhang, YY | 1 |
| Chen, M; Yao, C; Ye, W | 1 |
| Ahmad, N; Chhabra, G; Longley, BJ; Mintie, CA; Ndiaye, MA; Roy, S; Schieke, SM; Singh, CK; Sullivan, R | 1 |
| Cui, K; Feng, Y; Gu, L; Hu, J; Hu, Y; Huang, N; Li, G; Li, J; Li, W; Li, Y; Wang, X; Wu, W; Yu, J; Yue, C; Zeng, F; Zhao, F; Zhou, P | 1 |
| Delcour, JA; Fogliano, V; Kalailingam, P; Lee, YH; Thanabalu, T | 1 |
| Cao, X; Chen, S; Fang, M; Nie, T; Tang, L | 1 |
| Du, B; Hu, Q; Huang, H; Li, P; Li, W; Xu, X; Zhang, Y; Zhao, W | 1 |
| Chen, HX; Chu, S; Dong, CZ; Du, ZY; Li, M; Li, YL; Liang, YH; Meunier, B; Shu, P; Ye, ZH | 1 |
| Ahn, HJ; Cho, JJ; Kim, JH; Kim, YS; Lee, S; Park, CS; Park, YS | 1 |
| Chen, W; Fang, Z; Lee, YK; Li, L; Lu, W; Zhang, H; Zhao, J | 1 |
| Avlas, S; Azouz, NP; Benhar, I; Bitton, A; Diesendruck, Y; Itan, M; Karo-Atar, D; Munitz, A; Nahary, L; Reichman, H; Rothenberg, ME; Rozenberg, P | 1 |
| Cheng, YH; Deng, ZX; Ding, H; Li, J; Li, XL; Tang, L; Xiao, Y | 1 |
| Chong, HJ; Jang, S; Jeon, YE; Jeong, H; Ju, BG; Kim, KH; Kim, SI; Lee, K; Lee, SJ; Lee, YS; Shin, DS; Shin, JY | 1 |
| Cao, X; Ding, H; Li, X; Tang, L | 1 |
| Chen, D; Jia, J; Li, H; Lin, Y; Liu, J; Mo, X; Yan, F; Ye, S; Zhang, Y | 1 |
| Cheng, L; Dong, J; Feng, Y; Huang, C; Jiang, J; Wang, F; Wu, B; Xie, T; Xiong, X; Zhang, D | 1 |
| Chen, J; Chen, S; Xu, Y | 1 |
| Liu, D; Man, MQ; Wen, S; Yang, B; Ye, L | 1 |
| Fujimoto, M; Fujisawa, Y; Ichimura, Y; Ishitsuka, Y; Kubota, N; Mizuno, S; Nakamura, Y; Okiyama, N; Saito, A; Takahashi, S; Tanaka, R; Watanabe, R | 1 |
| Heo, JC; Lee, S; Lee, SH; Son, HU | 1 |
| Cho, IH; Choi, SH; Hwang, SH; Jang, M; Kim, HC; Kim, HJ; Kim, HK; Lee, BH; Nah, SY; Rhim, H | 1 |
| Arima, H; Higashi, T; Kaneko, S; Motoyama, K; Sakai, A; Tanida, Y | 1 |
| Jeong, HJ; Kim, HM; Nam, SY; Wan Yoon, K; Yoou, MS | 1 |
| Aizawa, S; Kitamura, A; Takata, R; Wada, T; Watanabe, H | 1 |
| Ito, D; Ohkusu-Tsukada, K; Takahashi, K | 1 |
| Jeong, HJ; Kim, HM; Ryu, KJ; Seo, Y; Yoon, KW; Yoou, MS | 1 |
| Han, NR; Jeong, HJ; Kim, HM; Moon, PD; Ryu, KJ; Yoo, MS | 1 |
| Guo, JZ; Li, LF; Wang, J; Wang, WH; Yang, SM | 1 |
| Chang, TS; Han, NR; Jeong, HJ; Kim, HM; Moon, PD; Yoou, MS | 1 |
| Han, NR; Jeong, HJ; Kim, HM; Moon, PD | 3 |
| Han, NR; Hong, S; Jee, HW; Jeong, HJ; Kang, S; Kim, HJ; Kim, HM; Kim, JH; Lee, JS; Moon, PD; Yoo, MS | 1 |
| Qu, Y; Sun, X; Wang, G; Wang, K | 1 |
| Cho, K; Kim, BH; Kim, SY; Lee, WJ; Park, HY; Sanjel, B; Shim, WS; Son, YK | 1 |
| Liu, Y; Sun, G; Wang, Y; Yin, B; Zhu, L | 1 |
| Choi, JK; Kim, SH | 1 |
| Ahn, HJ; Cho, JJ; Kim, GD; Kim, TH; Park, CS; Park, YS | 2 |
| Han, NR; Jang, JB; Jeong, HJ; Kang, SW; Kim, HM; Moon, PD | 1 |
| Kim, GD; Lee, SE; Park, CS; Park, GG; Park, YS; Shin, DH | 1 |
| Hussain, Z; Katas, H; Kumolosasi, E; Mohd Amin, MC; Sahudin, S | 1 |
| Hussain, Z; Katas, H; Kumolosasi, E; Mohd Amin, MC | 1 |
| Han, NR; Jang, JB; Jeong, HJ; Kim, HM; Park, JY | 1 |
| Feng, S; Nie, L; Suo, J; Zou, P | 1 |
| Kim, TY; Lee, EJ; Lee, JH; Lee, YS | 1 |
| Endo, T; Hamasaki, T; Kanazawa, T; Ohgi, T; Okada, H; Seta, Y; Sogabe, K; Tamano, K | 1 |
| Ahn, HJ; Cho, JJ; Kim, GD; Park, CS; Park, YS | 1 |
| Cheng, RH; Gu, Y; Li, CX; Li, HG; Li, M; Liang, JY; Ling, B; Yao, ZR; Yu, H; Zhang, H | 1 |
| Aoyanagi, N; Itabashi, Y; Nishimura, K; Uchino, E | 1 |
| Arimura, A; Deguchi, M; Furue, Y; Haruna, T; Hayakawa, J; Imura, K; Morioka, Y; Soga, M; Yamamoto, M; Yasui, K | 1 |
| Fujieda, Y; Fukuda, Y; Maruoka, H; Muto, T; Nagahira, K; Nakatsuka, T; Ogata, A; Tanaka, T; Terakawa, M; Tomimori, Y | 1 |
| Jung, JA; Jung, SK; Kim, DY; Kim, TH; Park, CS; Seo, SW | 1 |
| Ahn, HJ; Jang, AH; Jung, JA; Kim, GD; Kim, TH; Park, CS; Park, YS | 1 |
| Fujii, Y; Sengoku, T; Takakura, S | 1 |
| Asai, S; Inagaki, N; Ito, T; Kato, H; Nagai, H; Tanaka, H; Yamashita, H | 1 |
| Cho, JJ; Jang, AH; Jung, JA; Kim, GD; Kim, TH; Park, CS; Park, YS | 1 |
| Ezaki, T; Inagaki, N; Miyamoto, Y; Nagai, H; Shah, MM; Tanaka, H; Yamada, Y; Yamashita, H | 1 |
| Ahn, HJ; Jang, AH; Kim, GD; Kim, TH; Park, CS; Park, YS | 1 |
| Byeon, SE; Cho, JY; Kim, TW; Li, L; Park, CW; Park, HJ; Sung, GH; Wu, G | 1 |
| Ahn, KS; Bae, H; Hur, YG; Kim, JJ; Kim, MS; Kim, WG; Park, BW | 1 |
| Guo, JY; Li, RZ; Liu, W; Ma, HM; Wang, RY; Yuan, XY | 1 |
| Jang, AH; Jin, YH; Kim, GD; Kim, HJ; Kim, JE; Kim, SS; Kim, TH; Park, CS; Park, YS | 1 |
| Heo, JC; Lee, SH; Nam, DY; Seo, MS | 1 |
| Heo, JC; Lee, JM; Lee, SH; Nam, DY | 1 |
| Iwao, H; Izumi, Y; Miura, K; Nakao, T; Osada-Oka, M; Samukawa, K; Shiota, M | 1 |
| Jin, YH; Kim, GD; Kim, TH; Park, CS; Park, YS | 1 |
| Choi, JH; Choi, SY; Kim, D; Kim, HJ; Kwon, HJ; Kwon, S; Lee, Y; Park, BK; Park, J; Park, MC | 1 |
| Heo, JC; Kim, SL; Lee, SH; Son, HU | 1 |
| Buang, F; Hussain, Z; Katas, H; Kumolosasi, E; Mohd Amin, MC; Sahudin, S | 1 |
| Kouda, K; Nakamura, H; Takeuchi, H; Tokunaga, R | 1 |
| Atsumi, Y; Chang, HW; Hisada, M; Inagaki, N; Ishii, S; Kikuchi-Yanoshita, R; Koga, K; Kudo, I; Moon, TC; Murakami, M; Nagai, H; Saito, T; Sawada, M; Sugiki, T; Suzuki-Nishimura, T; Taketomi, Y; Uchida, MK | 1 |
| Fukuda, Y; Goto, M; Tanaka, Y; Tomimori, Y | 1 |
| Al-Hassani, M; Billings, SD; Howard, KM; Ishii, S; Mousdicas, N; Perkins, SM; Shimizu, T; Travers, JB; Yi, Q; Zhang, Q | 1 |
| Chikumoto, T; Igeta, K; Inagaki, N; Itoh, T; Kim, JF; Nagai, H; Nagao, M; Shiraishi, N | 1 |
| Miyagawa, N; Ueda, Y; Wakitani, K | 1 |
| Ahn, HJ; Cho, JJ; Geum, D; Lee, SJ; Oh, SG; Park, CS; Seo, SW | 1 |
| Kim, D; Kim, J; Kim, YJ; Kwon, HJ; Kwon, S; Lee, S; Lee, Y; Park, CS; Park, KL; Seo, JN | 1 |
| Katayama, I; Minatohara, K; Nishioka, K; Yokozeki, H | 1 |
| Andoh, T; Hase, K; Hayashi, K; Kadota, S; Kuraishi, Y; Murakami, K; Nagai, H; Saiki, I; Satoh, T; Tahara, E; Watanabe, C | 1 |
| Itoh, T; Nagai, H; Saiki, I; Satoh, T; Tahara, E; Terasawa, K; Watanabe, C; Yamada, T | 1 |
| Michaelides, MC; Simms, ES | 1 |
| Baer, RL; Rosenthal, SA | 1 |
| Di Saia, PJ; Friou, GJ; Harding, B; Levan, NE; Nies, KM; Quismorio, FP; Rea, TH | 1 |
95 other study(ies) available for dinitrofluorobenzene and Dermatitis, Atopic
| Article | Year |
|---|---|
Sarsasapogenin and fluticasone combination improves DNFB induced atopic dermatitis lesions in BALB/c mice.
Topics: Animals; Dermatitis, Atopic; Dermatologic Agents; Dinitrofluorobenzene; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Fluticasone; Inflammation Mediators; Male; Mice; Mice, Inbred BALB C; Spirostans; Toxicity Tests, Acute | 2021 |
Urinary lipid profile of atopic dermatitis in murine model and human patients.
Topics: Administration, Cutaneous; Animals; Biomarkers; Child; Child, Preschool; Chromatography, Liquid; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Female; Humans; Male; Mice; Mice, Inbred BALB C; Prostaglandins; Severity of Illness Index; Skin; Tandem Mass Spectrometry | 2021 |
TRPV1 mediates itch-associated scratching and skin barrier dysfunction in DNFB-induced atopic dermatitis mice.
Topics: Animals; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Mast Cells; Mice; Pruritus; Skin; TRPV Cation Channels | 2022 |
Different molecular weight hyaluronic acid alleviates inflammation response in DNFB-induced mice atopic dermatitis and LPS-induced RAW 264.7 cells.
Topics: Animals; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Humans; Hyaluronic Acid; Inflammation; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Molecular Weight; Phosphatidylinositol 3-Kinases; RAW 264.7 Cells; Skin; Tumor Necrosis Factor-alpha | 2022 |
Nicotinamide mononucleotide ameliorates DNFB-induced atopic dermatitis-like symptoms in mice by blocking activation of ROS-mediated JAK2/STAT5 signaling pathway.
Topics: Animals; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Mice; Nicotinamide Mononucleotide; Pruritus; Reactive Oxygen Species; Signal Transduction; Skin; STAT5 Transcription Factor; Tumor Necrosis Factor-alpha | 2022 |
Scutellarein attenuates atopic dermatitis by selectively inhibiting transient receptor potential vanilloid 3 channels.
Topics: Animals; Anti-Inflammatory Agents; Apigenin; Cymenes; Cysteine; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Humans; Immunoglobulin E; Inflammation; Mice; Mice, Knockout; Molecular Docking Simulation; RNA, Messenger; Transient Receptor Potential Channels; TRPV Cation Channels | 2022 |
Cold Plasma Irradiation Attenuates Atopic Dermatitis
Topics: Animals; Dermatitis, Atopic; Dinitrofluorobenzene; Endoplasmic Reticulum Stress; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Nerve Growth Factors; Plasma Gases | 2022 |
Calcium-Based Antimicrobial Peptide Compounds Attenuate DNFB-Induced Atopic Dermatitis-Like Skin Lesions via Th-Cells in BALB/c Mice.
Topics: Animals; Antimicrobial Peptides; Calcium; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Inflammation Mediators; Mice; Mice, Inbred BALB C; Skin; T-Lymphocytes, Helper-Inducer; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2022 |
Combined application of dinitrofluorobenzene and ovalbumin induced AD-like dermatitis with an increase in helper T-cell cytokines and a prolonged Th2 response.
Topics: Animals; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Female; Humans; Mice; Ovalbumin; T-Lymphocytes, Helper-Inducer | 2022 |
Dictamnine ameliorates chronic itch in DNFB-induced atopic dermatitis mice via inhibiting MrgprA3.
Topics: Animals; Dermatitis, Atopic; Dinitrofluorobenzene; Histamine; Mice; Molecular Docking Simulation; Pruritus; Quinolines; Receptors, G-Protein-Coupled; Sensory Receptor Cells; Transient Receptor Potential Channels | 2023 |
Molecular Mechanisms of Luteolin Against Atopic Dermatitis Based on Network Pharmacology and in vivo Experimental Validation.
Topics: Animals; Dermatitis, Atopic; Dinitrofluorobenzene; Drugs, Chinese Herbal; Luteolin; Mice; Molecular Docking Simulation; Network Pharmacology | 2022 |
Myricetin treatment has ameliorative effects in DNFB-induced atopic dermatitis mice under high-fat conditions.
Topics: Animals; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Filaggrin Proteins; Flavonoids; Mice; NF-kappa B; RNA, Messenger; Skin | 2023 |
Inhibition of Mast Cell Degranulation in Atopic Dermatitis by Celastrol through Suppressing MRGPRX2.
Topics: Animals; Cell Degranulation; Dermatitis, Atopic; Dinitrofluorobenzene; Mast Cells; Receptors, G-Protein-Coupled; Receptors, Neuropeptide | 2023 |
Protective effects of dietary grape against atopic dermatitis-like skin lesions in NC/NgaTndCrlj mice.
Topics: Animals; Dermatitis, Atopic; Diet; Dinitrofluorobenzene; Mice; Skin Diseases; Vitis | 2022 |
WFDC12-overexpressing contributes to the development of atopic dermatitis via accelerating ALOX12/15 metabolism and PAF accumulation.
Topics: Animals; Arachidonate 12-Lipoxygenase; Arachidonic Acid; Dermatitis, Atopic; Dinitrofluorobenzene; Humans; Mice; Platelet Activating Factor; Proteins; Skin | 2023 |
Olive-Derived Antioxidant Dietary Fiber Modulates Gut Microbiota Composition and Attenuates Atopic Dermatitis Like Inflammation in Mice.
Topics: Animals; Antioxidants; Butyrates; Dermatitis, Atopic; Dietary Fiber; Dinitrofluorobenzene; Gastrointestinal Microbiome; Immunoglobulin E; Inflammation; Mice; Olea | 2023 |
Fructo-oligofructose ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions and psychiatric comorbidities in mice.
Topics: Animals; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Female; Inflammation; Mice; Skin | 2023 |
Probiotic-fermented Portulaca oleracea L. alleviated DNFB-induced atopic dermatitis by inhibiting the NF-κB signaling pathway.
Topics: Animals; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; I-kappa B Kinase; Immunoglobulin E; Mice; NF-kappa B; NF-KappaB Inhibitor alpha; Portulaca; Signal Transduction; Thymic Stromal Lymphopoietin; Tumor Necrosis Factor-alpha | 2023 |
GDU-952, a novel AhR agonist ameliorates skin barrier abnormalities and immune dysfunction in DNFB-induced atopic dermatitis in mice.
Topics: Animals; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Keratinocytes; Mice; Receptors, Aryl Hydrocarbon; Skin | 2023 |
NXP081, DNA Aptamer-Vitamin C Complex Ameliorates DNFB-Induced Atopic Dermatitis in Balb/c Mice.
Topics: Animals; Aptamers, Nucleotide; Ascorbic Acid; CD4-Positive T-Lymphocytes; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Mice; Mice, Inbred BALB C; Skin; Skin Diseases; Vitamins | 2023 |
Bifidobacteria adolescentis regulated immune responses and gut microbial composition to alleviate DNFB-induced atopic dermatitis in mice.
Topics: Animals; Bifidobacterium adolescentis; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Gastrointestinal Microbiome; Immunity; Mice | 2020 |
A key role for IL-13 signaling via the type 2 IL-4 receptor in experimental atopic dermatitis.
Topics: Animals; Dermatitis, Atopic; Dinitrofluorobenzene; Female; Interleukin-13; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxazolone; Receptors, Interleukin-4, Type II; Signal Transduction | 2020 |
Conjugated linoleic acid attenuates 2,4-dinitrofluorobenzene-induced atopic dermatitis in mice through dual inhibition of COX-2/5-LOX and TLR4/NF-κB signaling.
Topics: Animals; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Cyclooxygenase 2; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Dinoprostone; Humans; Leukotriene B4; Linoleic Acids, Conjugated; Male; Mast Cells; Mice; Myeloid Differentiation Factor 88; NF-kappa B; Signal Transduction; Skin; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2020 |
Caffeoyl-Prolyl-Histidine Amide Inhibits Fyn and Alleviates Atopic Dermatitis-Like Phenotypes via Suppression of NF-κB Activation.
Topics: Amides; Animals; Anti-Inflammatory Agents; Atrophy; Caffeic Acids; Dermatitis, Atopic; Dinitrofluorobenzene; Dipeptides; Disease Models, Animal; Female; Gene Expression Regulation; Glycoconjugates; HaCaT Cells; Humans; I-kappa B Kinase; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; NF-kappa B; Protein Binding; Proto-Oncogene Proteins c-fyn; Signal Transduction; Skin; Syk Kinase; TOR Serine-Threonine Kinases; Transcription Factors | 2020 |
Topical application with conjugated linoleic acid ameliorates 2, 4-dinitrofluorobenzene-induced atopic dermatitis-like lesions in BALB/c mice.
Topics: Administration, Cutaneous; Animals; Behavior, Animal; Cyclooxygenase 2; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Filaggrin Proteins; Hydrogen-Ion Concentration; Immunoglobulin E; Interleukin-1beta; Interleukin-6; Linoleic Acids, Conjugated; Male; Mice; Mice, Inbred BALB C; NF-KappaB Inhibitor alpha; Nitric Oxide Synthase Type II; Phosphorylation; Skin Physiological Phenomena; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2021 |
Role of YAP-related T cell imbalance and epidermal keratinocyte dysfunction in the pathogenesis of atopic dermatitis.
Topics: Acute Disease; Adaptor Proteins, Signal Transducing; Adolescent; Adult; Animals; Apoptosis; Cell Differentiation; Child; Chronic Disease; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Down-Regulation; Epidermis; Female; HaCaT Cells; Humans; Keratinocytes; Male; Mice; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells; Th2 Cells; Transcription Factors; Up-Regulation; YAP-Signaling Proteins; Young Adult | 2021 |
Qingxue jiedu formulation ameliorated DNFB-induced atopic dermatitis by inhibiting STAT3/MAPK/NF-κB signaling pathways.
Topics: Animals; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Drugs, Chinese Herbal; Immunoglobulin E; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; STAT3 Transcription Factor | 2021 |
Profiling transcriptomic changes and signaling pathways in atopic dermatitis by integrative analyses on multiple databases.
Topics: Animals; Computational Biology; Databases, Genetic; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Gene Regulatory Networks; Humans; Male; Mice; Protein Interaction Maps; Signal Transduction | 2021 |
Topical N-palmitoyl serinol, a commensal bacterial metabolite, prevents the development of epidermal permeability barrier dysfunction in a murine model of atopic dermatitis-like skin.
Topics: Administration, Topical; Animals; Dermatitis, Atopic; Dinitrofluorobenzene; Mice; Mice, Inbred C57BL; Propanolamines; Propylene Glycols; Water Loss, Insensible | 2021 |
Differential Involvement of Programmed Cell Death Ligands in Skin Immune Responses.
Topics: Animals; Antigen Presentation; B7-H1 Antigen; Calcitriol; Cells, Cultured; Cytokines; Dendritic Cells; Dermatitis, Atopic; Dermatitis, Contact; Dinitrofluorobenzene; Disease Models, Animal; Humans; Imiquimod; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Programmed Cell Death 1 Ligand 2 Protein; Psoriasis; Skin; Th1 Cells; Th17 Cells; Th2 Cells | 2022 |
The solid-state fermentation of Artemisia capillaris leaves with Ganoderma lucidum enhances the anti-inflammatory effects in a model of atopic dermatitis.
Topics: Animals; Anti-Inflammatory Agents; Artemisia; Basidiomycota; Biological Products; Biopsy; Cell Line; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Fermentation; Male; Matrix Metalloproteinases; Mice; Nitric Oxide; Nitric Oxide Synthase Type III; Plant Extracts; Plant Leaves | 2017 |
Effects of Gintonin-Enriched Fraction in an Atopic Dermatitis Animal Model: Involvement of Autotaxin Regulation.
Topics: Administration, Oral; Animals; Case-Control Studies; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Male; Mice; Phosphoric Diester Hydrolases; Plant Extracts | 2017 |
Anti-allergic effects of novel sulfated polysaccharide sacran on mouse model of 2,4-Dinitro-1-fluorobenzene-induced atopic dermatitis.
Topics: Animals; Anti-Allergic Agents; B-Lymphocytes; Biomarkers; Cell Proliferation; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Epidermis; Immunoglobulin E; Mice; Polysaccharides; Sulfates; T-Lymphocytes; Water | 2018 |
Bamboo salt suppresses skin inflammation in mice with 2, 4-dinitrofluorobenzene-induced atopic dermatitis.
Topics: Animals; Caspase 1; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Female; Histamine; Humans; Immunoglobulin E; Interleukin-13; Interleukin-5; Mice; Mice, Inbred BALB C; Sodium Chloride, Dietary | 2018 |
A murine model of atopic dermatitis can be generated by painting the dorsal skin with hapten twice 14 days apart.
Topics: Animals; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Female; Haptens; Immunoglobulin E; Interleukins; Mast Cells; Mice; Mice, Inbred BALB C; Skin | 2018 |
The Role of Proteasome Inhibitor MG132 in 2,4-Dinitrofluorobenzene-Induced Atopic Dermatitis in NC/Nga Mice.
Topics: Animals; CD8-Positive T-Lymphocytes; Cells, Cultured; Dermatitis, Atopic; Dinitrofluorobenzene; Immunoglobulin E; Interferon-gamma; Leupeptins; Male; Mast Cells; Mice; Mice, Inbred BALB C; Proteasome Inhibitors; Th1 Cells; Th2 Cells | 2018 |
Therapeutic effects of Artemisia scoparia Waldst. et Kitaib in a murine model of atopic dermatitis.
Topics: Administration, Topical; Animals; Artemisia; Caspase 1; Chlorogenic Acid; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Medicine, Korean Traditional; Mice; Mice, Inbred BALB C; Phytotherapy; Plant Extracts; RNA, Messenger; Skin | 2018 |
Regulatory effects of chrysophanol, a bioactive compound of AST2017-01 in a mouse model of 2,4-dinitrofluorobenzene-induced atopic dermatitis.
Topics: Animals; Anthraquinones; Cordyceps; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Female; Histamine; Mice, Inbred BALB C; Rumex; Skin | 2018 |
The role of metallothionein in a dinitrofluorobenzene-induced atopic dermatitis-like murine model.
Topics: Animals; Antioxidants; CD4-Positive T-Lymphocytes; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Edema; Gene Expression Regulation; Humans; Metallothionein; Mice; Mice, Knockout; NADH Dehydrogenase; Superoxide Dismutase | 2018 |
Effect of massage therapy by VOSKIN 125+ painkiller® on inflammatory skin lesions.
Topics: Animals; Behavior, Animal; Caspase 1; Chemokine CCL17; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Gene Expression; Immunoglobulin E; Interleukin-4; Interleukin-6; Massage; Mice; RNA, Messenger; Thymic Stromal Lymphopoietin; Time Factors; Tumor Necrosis Factor-alpha | 2018 |
Cordycepin ameliorates skin inflammation in a DNFB-challenged murine model of atopic dermatitis.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Deoxyadenosines; Dermatitis, Atopic; Dinitrochlorobenzene; Dinitrofluorobenzene; Disease Models, Animal; Female; Histamine; Immunoglobulin E; Mice; Mice, Inbred C57BL; Skin | 2018 |
Use of Physcion to Improve Atopic Dermatitis-Like Skin Lesions through Blocking of Thymic Stromal Lymphopoietin.
Topics: Animals; Caspase 1; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Emodin; Histamine; Humans; MAP Kinase Signaling System; Mast Cells; Mice; NF-kappa B; Thymic Stromal Lymphopoietin | 2019 |
Inhibition of the Warm Temperature-Activated Ca
Topics: Administration, Topical; Animals; Coumarins; Cymenes; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Dose-Response Relationship, Drug; Hot Temperature; Humans; Interleukin-6; Male; Mice; TRPV Cation Channels; Tumor Necrosis Factor-alpha; Up-Regulation | 2019 |
Extracts of the leaves of Pyrus ussuriensis Maxim. Alleviate itch sensation via TSLP-dependent manner in mouse models of atopic dermatitis.
Topics: Animals; Antipruritics; Calcium Signaling; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Ethanol; Ganglia, Spinal; HEK293 Cells; Humans; Male; Mice; Mice, Inbred ICR; Neurons; Plant Extracts; Pruritus; Pyroglyphidae; Pyrus; Solvents; Thymic Stromal Lymphopoietin | 2019 |
Tumor necrosis factor-α, monocyte chemoattractant protein-1 and intercellular adhesion molecule-1 increase during the development of a 2,4-dinitrofluorobenzene-induced immediate-type dermatitis in rats.
Topics: Animals; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Haptens; Immunoglobulin E; Intercellular Adhesion Molecule-1; Leukocytes; Male; Mast Cells; Rats; Rats, Sprague-Dawley | 2013 |
Rutin suppresses atopic dermatitis and allergic contact dermatitis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cytokines; Dermatitis, Allergic Contact; Dermatitis, Atopic; Dinitrochlorobenzene; Dinitrofluorobenzene; Disease Models, Animal; Female; Immunoglobulin E; Interferon-gamma; Mice; Mice, Inbred BALB C; Pyroglyphidae; Rutin; Tumor Necrosis Factor-alpha | 2013 |
The inhibitory effect of naringenin on atopic dermatitis induced by DNFB in NC/Nga mice.
Topics: Animals; Anti-Ulcer Agents; CD4-Positive T-Lymphocytes; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Ear; Edema; Flavanones; Immunoglobulin E; Inflammation; Interferon-gamma; Male; Mice; Skin | 2013 |
Genuine traditional Korean medicine, Naju Jjok (Chung-Dae, Polygonum tinctorium) improves 2,4-dinitrofluorobenzene-induced atopic dermatitis-like lesional skin.
Topics: Administration, Oral; Animals; Calcimycin; Caspase 1; Cell Line; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Drug Evaluation, Preclinical; Humans; Male; Medicine, Korean Traditional; Mice; Phytotherapy; Plant Extracts; Polygonum; Receptor-Interacting Protein Serine-Threonine Kinase 2; Tetradecanoylphorbol Acetate; Thymic Stromal Lymphopoietin; Tumor Necrosis Factor-alpha | 2014 |
Tryptanthrin ameliorates atopic dermatitis through down-regulation of TSLP.
Topics: Animals; Calcimycin; Calcium Ionophores; Cell Line; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Down-Regulation; Humans; Male; Mast Cells; Mice; Quinazolines; Skin; Spleen; Tetradecanoylphorbol Acetate; Thymic Stromal Lymphopoietin | 2014 |
Immunosuppressive effects of fisetin against dinitrofluorobenzene-induced atopic dermatitis-like symptoms in NC/Nga mice.
Topics: Animals; Base Sequence; CD4-Positive T-Lymphocytes; Dermatitis, Atopic; Dinitrofluorobenzene; DNA Primers; Flavonoids; Flavonols; Immunoglobulin E; Immunosuppressive Agents; Male; Mice; Polymerase Chain Reaction | 2014 |
Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisone-loaded chitosan nanoparticles.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Chitosan; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Down-Regulation; Drug Carriers; Hydrocortisone; Mice; Nanoparticles; Random Allocation | 2014 |
Efficient immuno-modulation of TH1/TH2 biomarkers in 2,4-dinitrofluorobenzene-induced atopic dermatitis: nanocarrier-mediated transcutaneous co-delivery of anti-inflammatory and antioxidant drugs.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Dinoprostone; Disease Models, Animal; Drug Carriers; Histamine; Hydrocortisone; Immunoglobulin E; Mice; Nanoparticles; Phenylethyl Alcohol; Skin; Th1 Cells; Th2 Cells; Vascular Endothelial Growth Factor A | 2014 |
A natural dye, Niram improves atopic dermatitis through down-regulation of TSLP.
Topics: Animals; Cell Line; Coloring Agents; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Gene Expression Regulation; Humans; Keratinocytes; Male; Medicine, Korean Traditional; Mice; Phytotherapy; Plant Extracts; Polygonum; Signal Transduction; Thymic Stromal Lymphopoietin | 2014 |
Drug-loaded PLGA-mPEG microparticles as treatment for atopic dermatitis-like skin lesions in BALB/c mice model.
Topics: Administration, Topical; Animals; Benzimidazoles; Delayed-Action Preparations; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Drug Carriers; Lactic Acid; Mice; Mice, Inbred BALB C; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2015 |
Immune response against 2,4-dinitrofluorobenzene-induced atopic dermatitis-like clinical manifestation is suppressed by spermidine in NC/Nga mice.
Topics: Animals; CD4-Positive T-Lymphocytes; Dermatitis, Atopic; Dinitrofluorobenzene; Histocytochemistry; Immunoglobulin E; Interferon-gamma; Interleukin-4; Male; Mice; Random Allocation; Specific Pathogen-Free Organisms; Spermidine | 2015 |
Capsiate Inhibits DNFB-Induced Atopic Dermatitis in NC/Nga Mice through Mast Cell and CD4+ T-Cell Inactivation.
Topics: Animals; Capsaicin; CD4-Positive T-Lymphocytes; Cell Differentiation; Cell Proliferation; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; MAP Kinase Signaling System; Mast Cells; Mice; Mice, Mutant Strains; Passive Cutaneous Anaphylaxis; Skin | 2015 |
Functional peptide nanocarriers for delivery of novel anti-RelA RNA interference agents as a topical treatment of atopic dermatitis.
Topics: Administration, Topical; Animals; Cell Line; Cell-Penetrating Peptides; Dermatitis, Atopic; Dinitrofluorobenzene; Interleukin-6; Mice; Oligopeptides; Peptides; RNA; RNA Interference; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2015 |
Aspartame Attenuates 2, 4-Dinitrofluorobenzene-Induced Atopic Dermatitis-Like Clinical Symptoms in NC/Nga Mice.
Topics: Analysis of Variance; Animals; Aspartame; Biopsy, Needle; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Flavanones; Humans; Immunoglobulin E; Immunohistochemistry; Male; Mice; Random Allocation | 2015 |
Andrographolide suppresses thymic stromal lymphopoietin in phorbol myristate acetate/calcium ionophore A23187-activated mast cells and 2,4-dinitrofluorobenzene-induced atopic dermatitis-like mice model.
Topics: Animals; Calcimycin; Cell Proliferation; Cell Survival; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Humans; Mast Cells; Mice; Molecular Conformation; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Thymic Stromal Lymphopoietin; Tumor Cells, Cultured | 2016 |
Influence of Hot Spring Water on Fatty Acid Composition of Skin Surface Lipids in Hairless Mouse Model of Atopic Dermatitis.
Topics: Animals; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Fatty Acids; Hot Springs; Immunoglobulin E; Lipid Metabolism; Male; Mice, Hairless; Petroleum; Skin | 2016 |
The Inhibitory Effect of S-777469, a Cannabinoid Type 2 Receptor Agonist, on Skin Inflammation in Mice.
Topics: Animals; Arachidonic Acids; Cell Migration Assays, Leukocyte; Dermatitis, Atopic; Dinitrofluorobenzene; Dose-Response Relationship, Drug; Endocannabinoids; Glycerides; Inflammation; Male; Mice; Mite Infestations; Pyridones; Receptor, Cannabinoid, CB2; Skin | 2017 |
Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis.
Topics: Administration, Oral; Animals; Azepines; Chymases; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Eosinophils; Female; Inflammation; Mast Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Pruritus; Skin | 2008 |
Oral administration of Uncariae rhynchophylla inhibits the development of DNFB-induced atopic dermatitis-like skin lesions via IFN-gamma down-regulation in NC/Nga mice.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; CD4-Positive T-Lymphocytes; Dermatitis, Atopic; Dinitrofluorobenzene; Down-Regulation; Female; Immunoglobulin E; Inflammation; Interferon-gamma; Interleukin-4; Lymph Nodes; Mice; Mice, Inbred Strains; Phytotherapy; Plant Extracts; Plant Roots; Prednisolone; Skin; Th1 Cells; Th2 Cells; Uncaria | 2009 |
Melatonin inhibits the development of 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice.
Topics: Animals; Antioxidants; Dermatitis, Atopic; Dinitrofluorobenzene; Male; Melatonin; Mice; Skin Diseases | 2009 |
Repeated topical application of glucocorticoids augments irritant chemical-triggered scratching in mice.
Topics: Administration, Topical; Animals; Betamethasone Valerate; Dermatitis, Atopic; Dermatitis, Irritant; Dexamethasone; Dinitrofluorobenzene; Disease Models, Animal; Disease Progression; Ear, External; Glucocorticoids; Mice; Mice, Inbred BALB C; Phorbol Esters; Skin Irritancy Tests | 2010 |
Comparison of the efficacy of tacrolimus and cyclosporine A in a murine model of dinitrofluorobenzene-induced atopic dermatitis.
Topics: Animals; Antipruritics; Behavior, Animal; Calcineurin Inhibitors; Capillary Permeability; Cyclosporine; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Passive Cutaneous Anaphylaxis; Pruritus; Tacrolimus | 2010 |
The histone deacetylase inhibitor, trichostatin A, inhibits the development of 2,4-dinitrofluorobenzene-induced dermatitis in NC/Nga mice.
Topics: Animals; CD4-Positive T-Lymphocytes; Dermatitis, Atopic; Dinitrofluorobenzene; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Histone Deacetylase Inhibitors; Hydroxamic Acids; Interferon-gamma; Interleukin-4; Mice; Mice, Inbred Strains | 2010 |
Orally supplemented Lactobacillus acidophilus strain L-92 inhibits passive and active cutaneous anaphylaxis as well as 2,4-dinitroflurobenzene and mite fecal antigen induced atopic dermatitis-like skin lesions in mice.
Topics: Administration, Oral; Anaphylaxis; Animals; Antigens, Dermatophagoides; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Female; Immunoglobulin E; Lactobacillus acidophilus; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Passive Cutaneous Anaphylaxis; Th1 Cells; Th2 Cells | 2010 |
α-Lipoic acid suppresses the development of DNFB-induced atopic dermatitis-like symptoms in NC/Nga mice.
Topics: Administration, Oral; Animals; Antioxidants; CD4-Positive T-Lymphocytes; Cell Proliferation; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Immunoglobulin E; Interferon-gamma; Interleukin-4; Male; Mice; Mice, Inbred Strains; Thioctic Acid | 2011 |
Inhibition of 2,4-dinitrofluorobenzene-induced atopic dermatitis by topical application of the butanol extract of Cordyceps bassiana in NC/Nga mice.
Topics: Administration, Topical; Animals; beta-N-Acetylhexosaminidases; Biological Products; Cattle; Cell Degranulation; Cordyceps; Dermatitis, Atopic; Dinitrofluorobenzene; Dose-Response Relationship, Drug; Epidermis; Histamine; Immunoglobulin E; Immunologic Factors; Interferon-gamma; Interleukin-4; Male; Mast Cells; Mice; Mice, Inbred Strains; Phytotherapy; Serum Albumin; Skin | 2011 |
Inhibitory effect of Platycodon grandiflorum on T(H)1 and T(H)2 immune responses in a murine model of 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions.
Topics: Animals; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Immunoglobulin E; Immunoglobulin G; Male; Mice; Phytotherapy; Plant Extracts; Platycodon; Skin; Th1 Cells; Th2 Cells | 2011 |
Topical application of aloperine improves 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice.
Topics: Administration, Topical; Animals; Dermatitis, Atopic; Dinitrofluorobenzene; Down-Regulation; Ear; Female; Immunoglobulin E; Interleukin-10; Mast Cells; Mice; Piperidines; Quinolizidines; Th1 Cells; Th2 Cells; Up-Regulation | 2011 |
Rosmarinic acid attenuates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cinnamates; Depsides; Dermatitis, Atopic; Dinitrofluorobenzene; Haptens; Immunoglobulin E; Interferon-gamma; Interleukin-4; Lymphocyte Activation; Male; Mast Cells; Mice; Rosmarinic Acid; Skin; Skin Diseases | 2011 |
Alleviation of atopic dermatitis-related symptoms by Perilla frutescens Britton.
Topics: Animals; Dermatitis, Atopic; Dinitrofluorobenzene; Eosinophils; Immunohistochemistry; Interleukins; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Perilla frutescens; Plant Extracts | 2011 |
Mitigation of 2,4-dinitrofluorobenzene-induced atopic dermatitis-related symptoms by Terminalia chebula Retzius.
Topics: Animals; CD4-Positive T-Lymphocytes; Dermatitis, Atopic; Dinitrofluorobenzene; Eosine Yellowish-(YS); Eosinophils; Hematoxylin; Interleukins; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Phytotherapy; Plant Extracts; Seeds; Skin; T-Box Domain Proteins; Terminalia | 2011 |
Effect of Pyeongwee-San (KMP6) on 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice.
Topics: Animals; Anti-Allergic Agents; Dermatitis, Atopic; Dinitrofluorobenzene; Male; Mice; Mice, Inbred Strains; Plant Extracts | 2012 |
Red ginseng inhibits scratching behavior associated with atopic dermatitis in experimental animal models.
Topics: Administration, Topical; Animals; Anti-Allergic Agents; Behavior, Animal; Capillary Permeability; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Ginsenosides; Histamine; Irritants; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Nerve Fibers; Nerve Growth Factor; Panax; Phytotherapy; Plant Extracts; Pruritus; Rats; Rats, Wistar | 2012 |
Omega-3 fatty acid-derived mediator, Resolvin E1, ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice.
Topics: Animals; CD4-Positive T-Lymphocytes; Dermatitis, Atopic; Dinitrofluorobenzene; Dose-Response Relationship, Drug; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Immunoglobulin E; Interferon-gamma; Interleukin-4; Male; Mice; Mice, Inbred Strains; Skin | 2012 |
Differential expression of cell surface markers in response to 2,4-dinitrofluorobenzene in RAW 264.7 and primary immune cells.
Topics: Animals; Antigens, CD; Antigens, Surface; B7-1 Antigen; Biomarkers; CD11b Antigen; CD83 Antigen; Cells, Cultured; Dendritic Cells; Dermatitis, Atopic; Dinitrofluorobenzene; Gene Expression Profiling; Histocompatibility Antigens Class II; Immunoglobulins; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Spleen | 2012 |
A derivative of L-allo threonine alleviates 2,4-dinitrofluorobenzene-induced atopic dermatitis indications.
Topics: Animals; Dermatitis, Atopic; Dinitrofluorobenzene; Epidermis; Gene Expression Regulation; Histamine; Hydrazines; Interleukin-17; Male; Mice; Mice, Inbred C57BL; Phenotype; Threonine | 2012 |
Self-assembled polymeric nanoparticles for percutaneous co-delivery of hydrocortisone/hydroxytyrosol: an ex vivo and in vivo study using an NC/Nga mouse model.
Topics: Animals; Anti-Inflammatory Agents; Chitosan; Dermatitis, Atopic; Dinitrofluorobenzene; Disease Models, Animal; Drug Carriers; Hydrocortisone; Mice; Nanoparticles; Phenylethyl Alcohol; Skin; Skin Absorption | 2013 |
Suppressive effects on delayed type hypersensitivity by fasting and dietary restriction in ICR mice.
Topics: Animals; Dermatitis, Atopic; Dinitrofluorobenzene; Fasting; Food Deprivation; Glucocorticoids; Histocytochemistry; Hormone Antagonists; Hypersensitivity, Delayed; Male; Mice; Mice, Inbred ICR; Mifepristone; Random Allocation | 2004 |
Induction of PYPAF1 during in vitro maturation of mouse mast cells.
Topics: 3T3 Cells; Amino Acid Sequence; Animals; Base Sequence; Carrier Proteins; Cell Differentiation; Cloning, Molecular; Coculture Techniques; Dermatitis, Atopic; Dinitrofluorobenzene; DNA, Complementary; Fibroblasts; Gene Expression Regulation; Humans; Mast Cells; Mice; Mice, Inbred BALB C; Molecular Sequence Data; RNA, Messenger; Sequence Alignment; Sequence Homology, Amino Acid | 2003 |
Repeated topical challenge with chemical antigen elicits sustained dermatitis in NC/Nga mice in specific-pathogen-free condition.
Topics: Animals; Antibodies; Antigens; CD4-Positive T-Lymphocytes; Dermatitis, Atopic; Dermatitis, Contact; Dinitrofluorobenzene; Ear, External; Immunoglobulin E; Interferon-gamma; Interleukin-12; Interleukin-18; Interleukin-4; Lymph Nodes; Mice; Mice, Inbred C3H; Mice, Mutant Strains; Specific Pathogen-Free Organisms | 2005 |
Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.
Topics: Animals; Calcium; Cell Line; Dermatitis, Atopic; Dinitrofluorobenzene; Drug Hypersensitivity; Drug Synergism; Humans; Hypersensitivity, Delayed; Inflammation; Interleukin-10; Lipopolysaccharides; Mice; Mice, Knockout; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Skin; Staphylococcal Infections; Staphylococcus aureus; Teichoic Acids; Th1 Cells; Th2 Cells | 2005 |
Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone.
Topics: Allergens; Anesthetics, Local; Animals; Antipruritics; Behavior, Animal; Dermatitis, Allergic Contact; Dermatitis, Atopic; Dexamethasone; Dibucaine; Dinitrofluorobenzene; Disease Models, Animal; Glucocorticoids; Immunoglobulin E; Interferon-gamma; Interleukin-4; Interleukin-5; Male; Mice; Mice, Inbred BALB C; Naloxone; Narcotic Antagonists; Pruritus; RNA, Messenger; Skin; Tacrolimus | 2006 |
Involvement of cannabinoid CB2 receptors in the IgE-mediated triphasic cutaneous reaction in mice.
Topics: Animals; Antibodies, Monoclonal; Camphanes; Dermatitis, Atopic; Dinitrofluorobenzene; Dioxoles; Dose-Response Relationship, Drug; Female; Immunoglobulin E; Ligands; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Pyrazoles; Quinolones; Receptor, Cannabinoid, CB2; Skin | 2007 |
Oral administration of Astragalus membranaceus inhibits the development of DNFB-induced dermatitis in NC/Nga mice.
Topics: Animals; Anti-Inflammatory Agents; Astragalus propinquus; CD4-Positive T-Lymphocytes; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Ear, External; Enzyme-Linked Immunosorbent Assay; Female; Immunoglobulin E; Interferon-gamma; Interleukin-4; Mice; Mice, Inbred Strains; Prednisolone; Skin | 2007 |
Regulation of macrophage inflammatory protein-2 gene expression in response to 2,4-dinitrofluorobenzene in RAW 264.7 cells.
Topics: Administration, Topical; Animals; Cell Line; Chemokine CXCL2; Chemotaxis, Leukocyte; Dermatitis, Atopic; Dermis; Dinitrofluorobenzene; Enzyme Activation; Gene Expression Regulation; Male; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins c-jun; Specific Pathogen-Free Organisms | 2008 |
Topical vitamin D3 downregulates IgE-mediated murine biphasic cutaneous reactions.
Topics: Administration, Topical; Animals; Antibodies, Anti-Idiotypic; Bone Marrow Cells; Cells, Cultured; Cholecalciferol; Croton Oil; Dermatitis, Atopic; Dinitrochlorobenzene; Dinitrofluorobenzene; Dinitrophenols; Dose-Response Relationship, Drug; Down-Regulation; Ear, External; Female; Haptens; Immunoglobulin E; Mice; Mice, Inbred BALB C; T-Lymphocytes | 1996 |
Inhibitory mechanisms of glycoprotein fraction derived from Miscanthus sinensis for the immediate phase response of an IgE-mediated cutaneous reaction.
Topics: Acute-Phase Reaction; Animals; Anti-Allergic Agents; Capillary Permeability; Dermatitis, Atopic; Dinitrofluorobenzene; Female; Glycoproteins; Immunoglobulin E; Mice; Mice, Inbred BALB C; Motor Activity; Pruritus; Zea mays | 1999 |
Differential effect of antiallergic drugs on IgE-mediated cutaneous reaction in passively sensitized mice.
Topics: Animals; Anti-Allergic Agents; Antibodies, Monoclonal; Chromones; Dermatitis, Atopic; Dinitrofluorobenzene; Histamine H1 Antagonists; Immunization, Passive; Immunoglobulin E; Leukotriene Antagonists; Mice; Mice, Inbred BALB C; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Skin Tests | 2000 |
Immune responses in mice infected with lactic dehydrogenase virus. II. Contact sensitization to DNFB and characterization of lymphoid cells during acute LDV infection.
Topics: Animals; Antigens; B-Lymphocytes; Dermatitis, Atopic; Dinitrofluorobenzene; Female; Lactate dehydrogenase-elevating virus; Lymph Nodes; Mice; Mice, Inbred BALB C; Nitrobenzenes; Receptors, Antigen, B-Cell; Spleen; T-Lymphocytes; Thymus Gland; Time Factors; Virus Diseases | 1977 |
Route of contact sensitization and in vitro lymphocyte transformation.
Topics: Animals; Dermatitis, Atopic; Dermatitis, Contact; Dinitrofluorobenzene; Freund's Adjuvant; Guinea Pigs; Lymphocyte Activation; Lymphocytes; Skin | 1978 |
Immunologic responses in patients with lepromatous leprosy.
Topics: Adult; Aged; Antigens; Autoantibodies; B-Lymphocytes; Dermatitis, Atopic; Dermatitis, Contact; Dinitrochlorobenzene; Dinitrofluorobenzene; Female; Humans; Lectins; Lepromin; Leprosy; Leukocyte Count; Lymphocyte Activation; Male; Middle Aged; Skin; T-Lymphocytes | 1976 |